Swedish biotech companies Immuneed AB and HepaPredict AB have entered into a collaboration agreement, the signing of which was announced today.
The agreement combines our two companies’ scientific expertise, specialized laboratory platforms and unique methodological know-how, enabling us to offer even better custimized solutions for our customers. HepaPredict’s expertise in hepatotoxicity predictions and pharmacokinetic assessments complements Immuneed’s strong focus on immediate immune-related responses in the human circulatory system after drug administration.
Through this collaboration, we will simplify our customers’ decision processes by giving them access to preclinically relevant human-based data that supports a more comprehensive characterization of modern biological drugs.
About Immuneed AB
Immuneed AB, founded in 2014, provides services to biotech and pharmaceutical companies. We address important questions related to drug safety and immunology, thereby cutting costs and adding value to drug development projects. Our goal is to provide truly meaningful insights that help our customers enter clinical trials prepared. Immuneed’s services are enabled by our proprietary platform based on circulating, fresh human blood. The platform links preclinical data to clinical reality ™– in the only commercially available system of its kind. www.immuneed.com
About HepaPredict AB
HepaPredict AB assists companies through the drug development process. By utilizing a unique 3D spheroid system composed of primary human hepatocytes and non-parenchymal cells, we mimic in vivo liver tissue – thus enabling us to provide clients with hepatotoxicity predictions and pharmacokinetic assessments for their candidate drugs. Our system can also be adjusted to mimic liver diseases, thereby functioning as a validation tool for novel therapeutics.
The HepaPredict’s 3D spheroid system minimizes the risk of encountering unexpected obstacles during the drug development process – creating value for clients and, ultimately, for patients. www.hepapredict.com